National hospital infection surveillance on methicillin-resistant Staphylococcus aureus

Hiroyoshi Kobayashi1

  • 1Tokyo Healthcare University, Tokyo, Japan. hk@kmc.mhc.east.ntt.co.jp

Dermatology (Basel, Switzerland)
|March 7, 2006
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) hospital infections in Japan remained stable from 1999-2003. This suggests current infection control measures are effective in preventing widespread MRSA prevalence.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Antimicrobial Resistance

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) prevalence has risen globally, prompting increased infection control recommendations.
  • Previous national surveillance in Japan (1995-1996) indicated MRSA rates, necessitating updated data.
  • Recent trends suggested stability, but reevaluation was crucial to confirm MRSA infection rates in Japanese hospitals.

Purpose of the Study:

  • To assess the incidence of MRSA hospital infections in Japan between 1999 and 2003.
  • To evaluate the effectiveness of existing MRSA infection control precautions in Japanese healthcare settings.

Main Methods:

  • Conducted a nationwide hospital infection surveillance study.
  • Collected data on MRSA infection incidence per 100 admissions.
  • Analyzed trends from 1999 to 2003.

Main Results:

  • MRSA infection incidence remained stable, ranging from 0.7 to 0.8 per 100 admissions.
  • A slight declining trend in MRSA hospital infections was observed during the study period.
  • Data confirmed the apparent stability of MRSA rates in Japanese hospitals.

Conclusions:

  • MRSA infection rates in Japanese hospitals have remained stable between 1999 and 2003.
  • The findings suggest that current infection control measures against MRSA in Japan are effective.
  • Continued surveillance is recommended to monitor future trends and maintain control.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...